Harbin Jixianglong Biotech Co., Ltd.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0380-2026 | Class II | Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106 | February 13, 2026 |
| D-0379-2026 | Class II | Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106- | February 13, 2026 |